Shareholders approve increase in CytoDyn authorized shares from 1B to 1.35B

CytoDyn Inc.

Stockholders voted 522,967,334 for, 19,601,702 against, 1,058,601 abstentions.
Total shares outstanding and entitled to vote: 809,522,060; 546,627,637 represented at special meeting.
Amendment to Certificate of Incorporation filed with Delaware Secretary of State on August 31, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.